Journal for ImmunoTherapy of Cancer (Oct 2021)
Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy
- Pascale Lejeune,
- Véronique Cruciani,
- Axel Berg-Larsen,
- Andreas Schlicker,
- Anne Mobergslien,
- Lisa Bartnitzky,
- Sandra Berndt,
- Sabine Zitzmann-Kolbe,
- Claudia Kamfenkel,
- Stefan Stargard,
- Stefanie Hammer,
- Jennifer S Jørgensen,
- Malene Jackerott,
- Carsten H Nielsen,
- Christoph A Schatz,
- Hartwig Hennekes,
- Jenny Karlsson,
- Alan S Cuthbertson,
- Dominik Mumberg,
- Urs B Hagemann
Affiliations
- Pascale Lejeune
- Bayer AG, Berlin, Germany
- Véronique Cruciani
- Bayer AS, Oslo, Norway
- Axel Berg-Larsen
- Bayer AS, Oslo, Norway
- Andreas Schlicker
- Bayer AG, Berlin, Germany
- Anne Mobergslien
- Bayer AS, Oslo, Norway
- Lisa Bartnitzky
- Bayer AG, Berlin, Germany
- Sandra Berndt
- Bayer AG, Berlin, Germany
- Sabine Zitzmann-Kolbe
- Bayer AG, Berlin, Germany
- Claudia Kamfenkel
- Bayer AG, Berlin, Germany
- Stefan Stargard
- Bayer AG, Berlin, Germany
- Stefanie Hammer
- Bayer AG, Berlin, Germany
- Jennifer S Jørgensen
- Minerva Imaging ApS, Copenhagen, Denmark
- Malene Jackerott
- Minerva Imaging ApS, Copenhagen, Denmark
- Carsten H Nielsen
- Minerva Imaging ApS, Copenhagen, Denmark
- Christoph A Schatz
- Bayer AG, Berlin, Germany
- Hartwig Hennekes
- Bayer AG, Berlin, Germany
- Jenny Karlsson
- Bayer AS, Oslo, Norway
- Alan S Cuthbertson
- Bayer AS, Oslo, Norway
- Dominik Mumberg
- Bayer AG, Berlin, Germany
- Urs B Hagemann
- Bayer AG, Berlin, Germany
- DOI
- https://doi.org/10.1136/jitc-2021-002387
- Journal volume & issue
-
Vol. 9,
no. 10
Abstract
No abstracts available.
